Clinical High and Genomic Low Hormone Receptor-positive Early Breast Cancer Patients With or Without Adjuvant Chemotherapy
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Early Hormone Receptor-positive Breast Cancer
Interventions: DRUG: Chemotherapy Drugs, Cancer
Sponsor: Gencurix, Inc.